Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02270372
Title Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oncothyreon Inc.
Indications

breast carcinoma

ovarian carcinoma

Therapies

Varlilumab

ONT-10

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UAB Comprehensive Cancer Center Birmingham Alabama 35294 United States Details
University of Colorado Aurora Colorado 80045 United States Details
NYU Perlmutter Cancer Center New York New York 10016 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field